AOBiome: Nature Scientific Reports has published a peer reviewed paper showing important immune response benefits associated with AOBiome's B244 Ammonia Oxidizing Bacteria drug therapy
CAMBRIDGE, Mass., July 15, 2021 /PRNewswire/ -- AOBiome Therapeutics, Inc. ('AOBiome'), a leading clinical-stage microbiome company focusing on in...
Read full article »
AOBiome focuses on developing skin care products that restore ammonia-oxidizing bacteria.
Read more